96 related articles for article (PubMed ID: 17255519)
21. Growth factor stimulation reduces residual quiescent chronic myelogenous leukemia progenitors remaining after imatinib treatment.
Holtz M; Forman SJ; Bhatia R
Cancer Res; 2007 Feb; 67(3):1113-20. PubMed ID: 17283145
[TBL] [Abstract][Full Text] [Related]
22. Tissue "Hypoxia" and the Maintenance of Leukemia Stem Cells.
Dello Sbarba P; Cheloni G
Adv Exp Med Biol; 2019; 1143():129-145. PubMed ID: 31338818
[TBL] [Abstract][Full Text] [Related]
23. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY
Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752
[TBL] [Abstract][Full Text] [Related]
24. Recurrence cancer stem cells--made by cell fusion?
Dittmar T; Nagler C; Schwitalla S; Reith G; Niggemann B; Zänker KS
Med Hypotheses; 2009 Oct; 73(4):542-7. PubMed ID: 19564079
[TBL] [Abstract][Full Text] [Related]
25. Functional alterations of Lin-CD34+CD38+ cells in chronic myelomonocytic leukemia and on progression to acute leukemia.
Sun Q; So CC; Yip SF; Wan TS; Ma SK; Chan LC
Leuk Res; 2008 Sep; 32(9):1374-81. PubMed ID: 18372040
[TBL] [Abstract][Full Text] [Related]
26. Cancer stem cells in solid tumors: an overview.
O'Brien CA; Kreso A; Dick JE
Semin Radiat Oncol; 2009 Apr; 19(2):71-7. PubMed ID: 19249644
[TBL] [Abstract][Full Text] [Related]
27. Lentiviral-mediated HoxB4 expression in human embryonic stem cells initiates early hematopoiesis in a dose-dependent manner but does not promote myeloid differentiation.
Unger C; Kärner E; Treschow A; Stellan B; Felldin U; Concha H; Wendel M; Hovatta O; Aints A; Ahrlund-Richter L; Dilber MS
Stem Cells; 2008 Oct; 26(10):2455-66. PubMed ID: 18617691
[TBL] [Abstract][Full Text] [Related]
28. PU.1: a crucial and versatile player in hematopoiesis and leukemia.
Kastner P; Chan S
Int J Biochem Cell Biol; 2008; 40(1):22-7. PubMed ID: 17374502
[TBL] [Abstract][Full Text] [Related]
29. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
[TBL] [Abstract][Full Text] [Related]
30. Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration.
Dennis JE; Esterly K; Awadallah A; Parrish CR; Poynter GM; Goltry KL
Stem Cells; 2007 Oct; 25(10):2575-82. PubMed ID: 17585167
[TBL] [Abstract][Full Text] [Related]
31. E2F-6 suppresses growth-associated apoptosis of human hematopoietic progenitor cells by counteracting proapoptotic activity of E2F-1.
Kikuchi J; Shimizu R; Wada T; Ando H; Nakamura M; Ozawa K; Furukawa Y
Stem Cells; 2007 Oct; 25(10):2439-47. PubMed ID: 17600109
[TBL] [Abstract][Full Text] [Related]
32. Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma.
Shiras A; Chettiar ST; Shepal V; Rajendran G; Prasad GR; Shastry P
Stem Cells; 2007 Jun; 25(6):1478-89. PubMed ID: 17332509
[TBL] [Abstract][Full Text] [Related]
33. Emergence of a subpopulation in a computational model of tumor growth.
Kansal AR; Torquato S; Chiocca EA; Deisboeck TS
J Theor Biol; 2000 Dec; 207(3):431-41. PubMed ID: 11082311
[TBL] [Abstract][Full Text] [Related]
34. Severe hypoxia selects hematopoietic progenitors with stem cell potential from primary Myelodysplastic syndrome bone marrow cell cultures.
Masala E; Valencia-Martinez A; Pillozzi S; Rondelli T; Brogi A; Sanna A; Gozzini A; Arcangeli A; Sbarba PD; Santini V
Oncotarget; 2018 Feb; 9(12):10561-10571. PubMed ID: 29535827
[TBL] [Abstract][Full Text] [Related]
35. The Culture-Repopulating Ability assays and incubation in low oxygen: a simple way to test drugs on leukaemia stem or progenitor cells.
Cipolleschi MG; Rovida E; Dello Sbarba P
Curr Pharm Des; 2013; 19(30):5374-83. PubMed ID: 23394087
[TBL] [Abstract][Full Text] [Related]
36. [Leukemia stem cells and their targeted clearance].
Liu B; Shi C; Zhou J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1120-3. PubMed ID: 25130840
[TBL] [Abstract][Full Text] [Related]
37. On the nature of the tumor-initiating cell.
Lara-Padilla E; Caceres-Cortes JR
Curr Stem Cell Res Ther; 2012 Jan; 7(1):26-35. PubMed ID: 22023623
[TBL] [Abstract][Full Text] [Related]
38. The Leukemic Stem Cell Niche: Adaptation to "Hypoxia" versus Oncogene Addiction.
Cheloni G; Poteti M; Bono S; Masala E; Mazure NM; Rovida E; Lulli M; Dello Sbarba P
Stem Cells Int; 2017; 2017():4979474. PubMed ID: 29118813
[TBL] [Abstract][Full Text] [Related]
39. Glutamine Availability Controls BCR/Abl Protein Expression and Functional Phenotype of Chronic Myeloid Leukemia Cells Endowed with Stem/Progenitor Cell Potential.
Poteti M; Menegazzi G; Peppicelli S; Tusa I; Cheloni G; Silvano A; Mancini C; Biagioni A; Tubita A; Mazure NM; Lulli M; Rovida E; Dello Sbarba P
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503182
[TBL] [Abstract][Full Text] [Related]
40. NOTCH-mediated ex vivo expansion of human hematopoietic stem and progenitor cells by culture under hypoxia.
Araki D; Fu JF; Huntsman H; Cordes S; Seifuddin F; Alvarado LJ; Cheruku PS; Cash A; Traba J; Li Y; Pirooznia M; Smith RH; Larochelle A
Stem Cell Reports; 2021 Sep; 16(9):2336-2350. PubMed ID: 34450041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
